Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin;} Dr. Jeffrey Lieberman is no slouch when it comes to understanding the human mind - particularly the diagnoses and treatment of mental illness. In addition to being chair of psychiatry at Columbia University, Dr. Lieberman sits on the advisory board of many of the world's largest drug companies. In this particular interview, Dr. Lieberman shares his thoughts around the most transformative technological developments in understanding the mind in the last 10 years - as well has his predictions as to which technologies and approaches will break the most ground in the future of diagnosing and treating mental illnesses.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related